| Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma (NCT00027742) | Memorial Sloan Kettering Cancer Center | 2001-05-01 |
| Vaccine Therapy in Treating Patients With Metastatic Cancer (NCT00021164) | National Cancer Institute (NCI) | 2001-05-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00017355) | Baylor Health Care System | 2001-04-01 |
| Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer (NCT00020540) | National Cancer Institute (NCI) | 2001-03-01 |
| Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma (NCT00017316) | National Cancer Institute (NCI) | 2001-03-01 |
| E7070 in Treating Patients With Stage IV Melanoma (NCT00014625) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-02-01 |
| PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma (NCT00238329) | Barbara Ann Karmanos Cancer Institute | 2001-01-01 |
| Vaccine Therapy in Treating Patients With Refractory Metastatic Melanoma (NCT00020397) | National Cancer Institute (NCI) | 2000-11-01 |
| Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma (NCT00016055) | St. Luke's Medical Center | 2000-11-01 |
| Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00007969) | QLT Inc. | 2000-10-01 |
| Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung (NCT00005610) | Alliance for Clinical Trials in Oncology | 2000-09-01 |
| Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma (NCT00006385) | Eastern Cooperative Oncology Group | 2000-09-01 |
| Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer (NCT00006022) | Virginia Commonwealth University | 2000-09-01 |
| S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma (NCT00006237) | SWOG Cancer Research Network | 2000-08-01 |
| Flavopiridol in Treating Patients With Metastatic Malignant Melanoma (NCT00005971) | NCIC Clinical Trials Group | 2000-07-04 |
| Vaccine Therapy in Treating Patients With Stage IV Melanoma (NCT00023647) | Mannkind Corporation | 2000-07-01 |
| Study of Families With Melanoma (NCT00445783) | Leeds Cancer Centre at St. James's University Hospital | 2000-07-01 |
| Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma (NCT00012064) | Lisata Therapeutics, Inc. | 2000-07-01 |
| Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma (NCT00016263) | Genta Incorporated | 2000-07-01 |
| O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma (NCT00005961) | National Cancer Institute (NCI) | 2000-06-01 |
| Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00006035) | H. Lee Moffitt Cancer Center and Research Institute | 2000-06-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00005841) | University of Southern California | 2000-06-01 |
| Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma (NCT00006249) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-06-01 |
| Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma (NCT00004244) | National Cancer Institute (NCI) | 2000-03-01 |
| Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma (NCT00005057) | National Human Genome Research Institute (NHGRI) | 2000-03-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00014456) | Dartmouth-Hitchcock Medical Center | 2000-03-01 |
| Gene Therapy in Treating Patients With Metastatic Melanoma (NCT00005943) | University of Colorado, Denver | 2000-02-01 |
| Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma (NCT00006233) | Fred Hutchinson Cancer Center | 2000-01-01 |
| High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma (NCT00447356) | Hackensack Meridian Health | 2000-01-01 |
| Vaccine Therapy in Treating Patients With Primary Stage II Melanoma (NCT00005052) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-12-01 |
| Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery (NCT00014092) | Saint Francis Hospital | 1999-12-01 |
| Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma (NCT00004148) | National Cancer Institute (NCI) | 1999-10-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00019994) | National Cancer Institute (NCI) | 1999-10-01 |
| Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis (NCT00004196) | University of Alabama at Birmingham | 1999-10-01 |
| Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery (NCT00006126) | Northwestern University | 1999-09-01 |
| Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery (NCT00004250) | Memorial Sloan Kettering Cancer Center | 1999-08-01 |
| S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases (NCT00003911) | SWOG Cancer Research Network | 1999-07-01 |
| Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (NCT00004065) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00019734) | National Cancer Institute (NCI) | 1999-07-01 |
| Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00006113) | University of Southern California | 1999-06-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00005633) | Memorial Sloan Kettering Cancer Center | 1999-06-01 |
| S9804: Vinorelbine in Treating Patients With Stage IV Melanoma (NCT00003828) | SWOG Cancer Research Network | 1999-05-01 |
| Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma (NCT00003897) | University of Wisconsin, Madison | 1999-05-01 |
| Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors (NCT00004016) | University of Rochester | 1999-04-01 |
| Vaccine Therapy in Treating Patients With Stage IV Melanoma (NCT00003665) | National Cancer Institute (NCI) | 1999-04-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00019721) | National Cancer Institute (NCI) | 1999-04-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00003792) | Baylor Health Care System | 1999-04-01 |
| Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin (NCT00003444) | Eastern Cooperative Oncology Group | 1999-03-29 |
| High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma (NCT00003641) | ECOG-ACRIN Cancer Research Group | 1999-03-25 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma (NCT00004025) | Genzyme, a Sanofi Company | 1999-03-01 |
| Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome (NCT00003601) | Eastern Cooperative Oncology Group | 1999-02-23 |
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer (NCT00004135) | University of Chicago | 1999-02-01 |
| Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma (NCT00003802) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1999-02-01 |
| PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma (NCT00004152) | Memorial Sloan Kettering Cancer Center | 1999-02-01 |
| Nitrocamptothecin in Treating Patients With Metastatic Melanoma (NCT00005875) | Astex Pharmaceuticals, Inc. | 1999-01-01 |
| Vaccine Therapy in Treating Patients With Melanoma (NCT00003556) | National Cancer Institute (NCI) | 1999-01-01 |
| Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma (NCT00003715) | AVAX Technologies | 1998-12-01 |
| Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors (NCT00003690) | Mayo Clinic | 1998-12-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00019487) | National Cancer Institute (NCI) | 1998-11-01 |
| Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma (NCT00003339) | University of Southern California | 1998-11-01 |
| Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00003568) | University of Illinois at Chicago | 1998-11-01 |
| Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma (NCT00003747) | Mount Vernon Cancer Centre at Mount Vernon Hospital | 1998-10-01 |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma (NCT00004141) | University of Chicago | 1998-08-01 |
| Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00004184) | University of Alabama at Birmingham | 1998-08-01 |
| ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma (NCT00003989) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-06-01 |
| Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma (NCT00004153) | University of Chicago | 1998-06-01 |
| Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma (NCT00004104) | NYU Langone Health | 1998-06-01 |
| Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma (NCT00003362) | Memorial Sloan Kettering Cancer Center | 1998-05-01 |
| Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma (NCT00003222) | University of Virginia | 1998-04-01 |
| Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery (NCT00003274) | University of Southern California | 1998-03-01 |
| Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma (NCT00019383) | National Cancer Institute (NCI) | 1998-01-01 |
| Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer (NCT00006368) | Novartis Pharmaceuticals | 1998-01-01 |
| Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma (NCT00003027) | Eastern Cooperative Oncology Group | 1997-11-13 |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00003346) | Memorial Sloan Kettering Cancer Center | 1997-11-01 |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors (NCT00019331) | National Cancer Institute (NCI) | 1997-10-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal (NCT00003229) | Duke University | 1997-07-01 |
| Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa (NCT00005615) | H. Lee Moffitt Cancer Center and Research Institute | 1997-07-01 |
| Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma (NCT00004022) | Barbara Ann Karmanos Cancer Institute | 1997-06-01 |
| Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer (NCT00003022) | Memorial Sloan Kettering Cancer Center | 1997-04-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00019214) | National Cancer Institute (NCI) | 1997-04-01 |
| Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma (NCT00002952) | University of Chicago | 1997-01-01 |
| S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma (NCT00898183) | SWOG Cancer Research Network | 1996-11-01 |
| SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma (NCT00002860) | SWOG Cancer Research Network | 1996-11-01 |
| Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer (NCT00002947) | Yale University | 1996-10-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma (NCT00019175) | National Cancer Institute (NCI) | 1996-08-01 |
| High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma (NCT00002763) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-04-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00002817) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 1996-04-01 |
| Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma (NCT00002781) | Beth Israel Deaconess Medical Center | 1996-04-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00003224) | University of Virginia | 1996-02-01 |
| Biological Therapy in Treating Patients With Metastatic Cancer (NCT00002733) | Hoag Memorial Hospital Presbyterian | 1996-01-01 |
| Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00002767) | GlaxoSmithKline | 1996-01-01 |
| High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma (NCT00003091) | Hoag Memorial Hospital Presbyterian | 1996-01-01 |
| Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma (NCT00002973) | University of Wisconsin, Madison | 1995-12-01 |
| Biological Therapy in Treating Patients With Metastatic Melanoma (NCT00002786) | Fred Hutchinson Cancer Center | 1995-10-01 |
| Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma (NCT00002892) | Institute of Cancer Research, United Kingdom | 1995-10-01 |
| Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00002669) | European Organisation for Research and Treatment of Cancer - EORTC | 1995-06-01 |
| Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma (NCT00003060) | Louisiana State University Health Sciences Center Shreveport | 1995-03-01 |
| Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas (NCT00019019) | National Institutes of Health Clinical Center (CC) | 1994-10-01 |
| Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma (NCT00002535) | St. Luke's Medical Center | 1993-07-01 |
| Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors (NCT00002754) | Duke University | 1993-02-01 |